Is azelastine nasal spray safe for treating common‑cold nasal symptoms in a patient with glaucoma?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: February 19, 2026View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Azelastine Nasal Spray is Safe in Glaucoma

Azelastine nasal spray is safe to use in patients with glaucoma for treating cold symptoms, as it lacks the anticholinergic and decongestant properties that increase intraocular pressure. 1

Why Azelastine is Safe in Glaucoma

  • Azelastine is a second-generation antihistamine that works through H1-receptor antagonism without significant anticholinergic effects, distinguishing it from first-generation antihistamines that can worsen glaucoma 2, 1

  • The medication that poses risk in glaucoma is the decongestant component (pseudoephedrine) found in combination cold preparations, not antihistamines like azelastine 3

  • First-generation antihistamines with anticholinergic properties can increase intraocular pressure, but azelastine does not have this mechanism of action 3

Evidence Supporting Safety

  • A 2022 comparative study explicitly states that azelastine can be safely used in patients with glaucoma and cataract due to its lesser side effects, making it a safer alternative to intranasal corticosteroids for long-term use 1

  • Guidelines recommend ipratropium bromide nasal spray as an alternative when first-generation antihistamine/decongestant combinations are contraindicated in glaucoma patients, but azelastine nasal spray does not carry this same contraindication 3

  • No specific contraindications are listed for azelastine formulations in glaucoma patients according to the American Academy of Otolaryngology-Head and Neck Surgery 2

Dosing for Cold Symptoms

  • Azelastine 0.15% (Astepro): 1-2 sprays per nostril twice daily for adults and children ≥12 years 2, 4

  • Azelastine 0.1% (Astelin): 1-2 sprays per nostril twice daily as an alternative formulation 2, 4

  • Onset of action occurs within 15 minutes, providing rapid relief of nasal symptoms 2, 4

Common Side Effects (Not Related to Glaucoma)

  • Bitter taste (4.5-8.3%) is the most common side effect, which can be minimized with correct dosing technique 5, 6

  • Somnolence rates are low (0.4-3%), comparable to placebo in recent studies 2, 4, 6

  • Nasal discomfort (4.5%) and epistaxis may occur but are generally mild 4, 5

What to Avoid in Glaucoma Patients

  • Avoid oral or nasal decongestants (pseudoephedrine, oxymetazoline) as these can increase intraocular pressure through sympathomimetic effects 3

  • Avoid first-generation antihistamines with strong anticholinergic properties (diphenhydramine, brompheniramine) as these can worsen glaucoma 3, 7

  • Do not combine azelastine with anticholinergic medications unnecessarily, though azelastine itself lacks significant anticholinergic activity 7

References

Research

Comparison of the Effects of Azelastine and Fluticasone Nasal Sprays in the Treatment of Allergic Rhinitis.

Indian journal of otolaryngology and head and neck surgery : official publication of the Association of Otolaryngologists of India, 2022

Guideline

Azelastine Efficacy and Safety for Allergic Rhinitis

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Guideline

Azelastine Nasal Spray Dosage and Treatment Plan for Allergic Rhinitis

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Research

Efficacy and safety of azelastine nasal spray at a dose of 1 spray per nostril twice daily.

Annals of allergy, asthma & immunology : official publication of the American College of Allergy, Asthma, & Immunology, 2007

Guideline

Safety of Combining Azelastine with Brompheniramine

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2026

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.